press release
June 30, 2016
The mutation is found in around half of patients diagnosed with ovarian
clear cell carcinoma.
References
*Miller et al., Synthetic
Lethal Targeting of
ARID1A mutant ovarian clear cell tumours with
dasatinib.
Molecular Cancer Therapeutics, 2016
don’t yet know exactly how it is
linked to cancer.
No comments:
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.